Clinical Course of Poorly Differentiated Pancreatic Adenocarcinoma after Surgical Resection

被引:0
|
作者
Hieda, N. [1 ]
Imaoka, H. [1 ]
Okuno, N. [1 ]
Yoshida, T. [1 ]
Sato, T. [1 ]
Tsutsumi, H. [1 ]
Hujiyoshi, T. [1 ]
Yogi, T. [1 ]
Ishihara, M. [2 ]
Tanaka, T. [2 ]
Hijioka, S. [1 ]
Hara, K. [1 ]
Tajika, M. [2 ]
Mizuno, N. [1 ]
Shimizu, Y. [3 ]
Niwa, Y. [2 ]
Yamao, K. [1 ]
机构
[1] Aichi Canc Ctr Hosp, Dept Gastroenterol, Nagoya, Aichi 464, Japan
[2] Aichi Canc Ctr Hosp, Dept Endoscopy, Nagoya, Aichi 464, Japan
[3] Aichi Canc Ctr Hosp, Dept Gastrointestinal Surg, Nagoya, Aichi 464, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1365 / 1366
页数:2
相关论文
共 50 条
  • [31] Long term survival after pancreatic resection for pancreatic adenocarcinoma
    Ahmad, NA
    Lewis, JD
    Ginsberg, GG
    Haller, DG
    Morris, JB
    Williams, NN
    Rosato, EF
    Kochman, ML
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (09): : 2609 - 2615
  • [32] ASO Author Reflections: Reconsidering Resection for Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma
    Kaslow, Sarah R.
    Correa-Gallego, Camilo
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3532 - 3533
  • [33] ASO Author Reflections: Reconsidering Resection for Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma
    Sarah R. Kaslow
    Camilo Correa-Gallego
    Annals of Surgical Oncology, 2022, 29 : 3532 - 3533
  • [34] Systematic review of the clinical significance of lymph node micrometastases of pancreatic adenocarcinoma following surgical resection
    Byeol, Sae
    Han, Hyung Joon
    Park, Pyoungjae
    Kim, Wan Bae
    Song, Tae-Jin
    Choi, Sang Yong
    PANCREATOLOGY, 2017, 17 (03) : 342 - 349
  • [35] Nomogram predicting overall and cancer specific prognosis for poorly differentiated lung adenocarcinoma after resection based on SEER cohort analysis
    Song, Weijian
    Shi, Jianwei
    Zhou, Boxuan
    Meng, Xiangzhi
    Liang, Mei
    Gao, Yushun
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] Predictors of Undergoing Surgical Resection after Neoadjuvant Chemoradiotherapy for Borderline Resectable and Resectable Pancreatic Adenocarcinoma
    Neibart, S. S.
    Mamidanna, S.
    Chundury, A.
    Sayan, M.
    Alexander, H. R.
    August, D.
    Berim, L. D.
    Boland, P. M.
    Grandhi, M. S.
    Gulhati, P.
    Kennedy, T. J.
    Langan, R. C.
    Spencer, K.
    Jabbour, S. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E63 - E64
  • [37] Factors associated with survival after surgical resection in Chinese patients with ductal adenocarcinoma of the pancreatic head
    Li, Qiang
    Gao, Chuntao
    Li, Huikai
    Juzi, Jonathan T.
    Chen, Hua
    Hao, Xishan
    DIGESTIVE SURGERY, 2008, 25 (02) : 87 - 92
  • [38] Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma
    Murakami, Yoshiaki
    Uemura, Kenichiro
    Sudo, Takeshi
    Hayashidani, Yasuo
    Hashimoto, Yasushi
    Nakagawa, Naoya
    Ohge, Hiroki
    Sueda, Taijiro
    AMERICAN JOURNAL OF SURGERY, 2008, 195 (06): : 757 - 762
  • [39] Long-term survival after curative resection for pancreatic ductal adenocarcinoma - Surgical treatment
    Benassai, G.
    Quarto, G.
    Perrotta, S.
    Furino, E.
    Benassai, G. L.
    Amato, B.
    Bianco, T.
    De Palma, G.
    Forestieri, P.
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 21 : S1 - S3
  • [40] Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
    Hu, Dingyuan
    Ansari, Daniel
    Zhou, Qimin
    Sasor, Agata
    Hilmersson, Katarzyna Said
    Andersson, Roland
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (01) : 95 - 100